Treatment of Depression in Older Adults

Carregando...
Imagem de Miniatura
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2012
Editora
SPRINGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CURRENT PSYCHIATRY REPORTS, v.14, n.4, p.289-297, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Depression is the most frequent mental disorder in older people, often causing emotional distress and reduced quality of life. Despite its clinical significance, depression remains underdiagnosed and inadequately treated in older patients. Regarding prognosis, data suggest that almost 70% of patients, treated long enough and with appropriate doses, recover from an index episode of depression. Antidepressants are efficient for treating depressed outpatients with several comorbid physical diseases as well as hospitalized patients, with selective serotonin reuptake inhibitors being the antidepressants of choice for older patients. Available data can guide pharmacological treatment in both the acute and maintenance stages, but further research is required to guide clinical strategies when remission is not achieved. Approaches for the management of resistance to treatment are summarized, including optimization strategies, drug changes, algorithms, and combined and augmentation pharmacological treatments. Finally, additional therapeutic choices such as electroconvulsive therapy, transcranial magnetic stimulation, and integrated psychotherapy are presented.
Palavras-chave
Depression, Aging, Older adults, Comorbidity, Polypharmacy, Antidepressants, Tricyclic antidepressants, Selective serotonin reuptake inhibitors, Serotonin and norepinephrine reuptake inhibitors, Monoamine oxidase inhibitors, Adverse effects, Treatment, Resistance to treatment, Recovery, Electroconvulsive therapy, Integrated psychotherapy
Referências
  1. Adli M, 2006, BIOL PSYCHIAT, V59, P1029, DOI 10.1016/j.biopsych.2006.05.010
  2. Alexopoulos GS, 2005, AM J PSYCHIAT, V162, P718, DOI 10.1176/appi.ajp.162.4.718
  3. Alexopoulos GS, 2001, POSTGRAD MED, P1
  4. Alexopoulos GS, 1998, CLIN GERIATRIC PSYCH, P184
  5. Andreescu C, 2011, PSYCHIAT CLIN N AM, V34, P335, DOI 10.1016/j.psc.2011.02.005
  6. Australian Bureau of Statistics, 1998, MENT HLTH WELLB PROF
  7. Australian Bureau of Statistics, 2008, NAT SURV MENT HLTH W
  8. Baldwin R, 2008, OXFORD TXB OLD AGE P, P529
  9. Baldwin RC, 2003, INT J GERIATR PSYCH, V18, P829, DOI 10.1002/gps.940
  10. Bauer M, 2007, WORLD J BIOL PSYCHIA, V8, P67, DOI 10.1080/15622970701227829
  11. Bauer M, 2009, J CLIN PSYCHOPHARM, V29, P327, DOI 10.1097/JCP.0b013e3181ac4839
  12. Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249
  13. Bottino CMC, 2003, INT CLIN PSYCHOPHARM, V18, pS39
  14. Bryant C, 2009, INT PSYCHOGERIATR, V21, P754, DOI 10.1017/S1041610209009399
  15. Carvalho AF, 2009, CURR OPIN PSYCHIATR, V22, P7, DOI 10.1097/YCO.0b013e32831be9ef
  16. Chemali Z, 2009, HARVARD REV PSYCHIAT, V17, P242, DOI 10.1080/10673220903129798
  17. Chiu E, 2009, DEPRESSIVE DISORDERS
  18. Cole MG, 1999, AM J PSYCHIAT, V156, P1182
  19. Cummings SM, 2002, HEALTH SOC WORK, V27, P293
  20. DeBattista C, 2006, J PSYCHOPHARMACOL, V20, P11, DOI 10.1177/13597868064310
  21. Fabre I, 2004, INT J GERIATR PSYCH, V19, P833, DOI 10.1002/gps.1172
  22. Fava GA, 2005, CLIN PSYCHOL-SCI PR, V12, P92, DOI 10.1093/clipsy/bpi011
  23. Favas M, 2009, CLIN PSYCHIATR, V70, P40
  24. Fleurence R, 2009, PSYCHOPHARMACOL BULL, V42, P57
  25. FLINT AJ, 1994, J CLIN PSYCHOPHARM, V14, P353
  26. Friedman MA, 2004, CLIN PSYCHOL-SCI PR, V11, P47, DOI 10.1093/clipsy/bph052
  27. Hays JC, 2001, AM J PSYCHIAT, V158, P1850, DOI 10.1176/appi.ajp.158.11.1850
  28. JOFFE RT, 1990, PSYCHIAT RES, V32, P241, DOI 10.1016/0165-1781(90)90029-5
  29. Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45
  30. Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001
  31. Lavretsky H, 2003, J CLIN PSYCHIAT, V64, P1410
  32. Lenze EJ, 2002, AM J PSYCHIAT, V159, P466, DOI 10.1176/appi.ajp.159.3.466
  33. Manes F, 2001, INT PSYCHOGERIATR, V13, P225, DOI 10.1017/S1041610201007608
  34. Mosimann UP, 2004, PSYCHIAT RES, V126, P123, DOI 10.1016/j.psychres.2003.10.006
  35. Mottram P., 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.PUB2
  36. Mulsant BH, 2001, INT J GERIATR PSYCH, V16, P585, DOI 10.1002/gps.465
  37. National Institute for Health and Clinical Excellence, 2004, DEPR MAN DEPR PRIM S
  38. Nelson JC, 2005, AM J GERIAT PSYCHIAT, V13, P227, DOI 10.1176/appi.ajgp.13.3.227
  39. O'Connor DW, 2006, AUST NZ J PSYCHIAT, V40, P623, DOI 10.1080/j.1440-1614.2006.01861.x
  40. Oestergaard S, 2011, PUBLIC HEALTH, V125, P357, DOI 10.1016/j.puhe.2011.02.001
  41. Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714
  42. Papakostas GI, 2006, DEPRESS ANXIETY, V23, P178, DOI 10.1002/da.20181
  43. Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39
  44. Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619
  45. Ross J, 2008, CAN J PSYCHIAT, V53, P117
  46. Salzman C, 2002, BIOL PSYCHIAT, V52, P265, DOI 10.1016/S0006-3223(02)01337-9
  47. Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541
  48. Shelton RC, 2010, CNS DRUGS, V24, P131, DOI 10.2165/11530280-000000000-00000
  49. Sienaert P, 2011, CAN J PSYCHIAT, V56, P5
  50. Small GW, 1998, CLIN GERIATRIC PSYCH, P245
  51. Staab JP, 2000, DEPRESS ANXIETY, V12, P63, DOI 10.1002/1520-6394(2000)12:1+<63::AID-DA8>3.0.CO;2-T
  52. Steffens David C, 2002, Psychopharmacol Bull, V36, P58
  53. Van der Wurff FB, 2003, COCHRANE DB SYST REV, DOI 10.1002/14651838.CD003593
  54. van Moltke LL, 1998, CLIN GERIATRIC PSYCH, P70
  55. Weihs KL, 2000, J CLIN PSYCHIAT, V61, P196
  56. WELLS KB, 1994, AM J PSYCHIAT, V151, P694
  57. Whyte EM, 2004, J CLIN PSYCHIAT, V65, P1634